Systemic Sclerosis is a chronic autoimmune condition that causes hardening and tightening of the skin and can affect internal organs such as the lungs, heart, and digestive system. It often leads to skin thickening, Raynaud’s phenomenon, and joint pain. The condition typically affects women between 30 and 50 years of age. Although rare, it can be serious if not treated early. Immune system dysfunction and genetic factors are believed to play a role in its development. Early intervention is crucial to manage symptoms, slow progression, and improve quality of life.
Additional symptoms may include shortness of breath, acid reflux, numbness in fingers, or swollen hands and feet. Early diagnosis and treatment with vasodilators, immunosuppressants, physical therapy, and organ-specific care can improve outcomes. Regular monitoring is essential to track progression, manage medications, and support long-term health and daily functioning.
Systemic Sclerosis is a chronic autoimmune condition that causes skin thickening and can affect internal organs, leading to serious complications if not properly managed.
Diagnosing Systemic Sclerosis involves identifying characteristic skin changes and evaluating potential internal organ involvement through clinical exams and tests.
Systemic Sclerosis is a lifelong condition, but prompt treatment can manage symptoms, limit complications, and support long-term health and function.
Non-pharmacologic therapies and supportive procedures can ease discomfort, improve function, and slow progression in Systemic Sclerosis.